A possible treatment and vaccine combination for COVID-19 has shown positive results in pre-clinical studies using human cells.
List view / Grid view
University of California San Francisco
Filter the results
Host pathways in coronavirus replication and COVID-19 pre-clinical drug target identification using proteomic and chemoinformatic analysis
The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains. Here, Joseph Steward highlights key findings of recent research.
Drugs that were being developed to treat enterovirus have also been found to treat certain cancers in mice.
Researchers have discovered a particular protein that is required for enterovirus replication and survival, presenting a therapeutic target.
Researchers have uncovered the architecture of the spindle pole body in yeast...
Researchers have turned skin cells from mice into stem cells by activating Sox2 and Oct4 using CRISPR technology...